Topics

Joshua H. Gordon, a student in the MD-PhD Program, is lead author of a study showing that postmenopausal women who have experienced loss of all teeth are at higher risk of developing high blood pressure.

Researchers in the Department of Emergency Medicine are the first to clinically assess and validate a rule regarding the length of observation time necessary before opioid overdose patients can be safely discharged from an emergency department (ED).

Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of medicine, spoke about the benefits of heart monitor apps for cardiac patients in a presentation at the 2019 Consumer Electronics Show (CES) in Las Vegas.

The Department of Surgery took part in a national initiative to give back to the less fortunate during the 2018 holiday season.

Elsa Bou Ghanem, PhD, assistant professor of microbiology and immunology, is conducting a four-year study on how white blood cells function against bacterial infections.

The Clinical and Translational Science Institute (CTSI) has recognized two Jacobs School of Medicine and Biomedical Sciences faculty members for their clinical research work.

When he heard about the first National Physician Suicide Awareness Day, Christian R. DeFazio, MD, clinical associate professor of emergency medicine and director of the emergency medicine residency program, wasn’t sure what to make of it.

University at Buffalo researchers have received a $2.7 million grant from the National Institutes of Health to continue their study of health outcomes among members of the military.

The number of students from underrepresented groups in the Jacobs School of Medicine and Biomedical Sciences Class of 2022 is nearly twice that of the previous year’s class.

The Hepatology Clinic at Erie County Medical Center (ECMC), under the direction of Anthony D. Martinez, MD, clinical associate professor of medicine, has been awarded a New York State Department of Health Commissioner’s Special Recognition Award.

Steven J. Fliesler, PhD, SUNY Distinguished Professor and the Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been awarded a $2.2 million grant from the National Eye Institute of the National Institutes of Health to better understand a rare cause of blindness that strikes young children.

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

Nonprescription use of Ritalin may cause irreversible structural changes in certain areas of the brain, according to researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions (CRIA).

Kenneth E. Leonard, PhD, professor of psychiatry and director of the UB Clinical and Research Institute on Addictions (CRIA), and Peter L. Elkin, MD, professor and chair of biomedical informatics, have been awarded a two-year, $386,013 grant from the National Institute on Alcohol Abuse and Alcoholism to assess what risks may occur for people with alcohol use disorder (AUD) who use prescription painkillers.

Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).

The Jacobs School of Medicine and Biomedical Sciences is using a New York State Department of Health grant to support the expansion of primary care residency and medical student training in ambulatory settings throughout Western New York.

Research by Richard M. Gronostajski, PhD, professor of biochemistry, reveals that the absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder.

The National Institutes of Health is funding researchers in the Department of Pharmacology and Toxicology to study the effects of drinking, smoking and marijuana use during pregnancy.

An innovative, cost-effective program at more than a dozen hospitals in Western New York provides medication-assisted treatment to opioid use disorder patients in emergency departments (EDs) and rapidly transitions them into long-term treatment at a community clinic, all within about 48 hours.